Skip Nav Destination
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study
Pediatric transplant–associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
Issue Archive
March 12 2024
Table of Contents
INSIDE BLOOD ADVANCES
CLINICAL TRIALS AND OBSERVATIONS
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD
Clinical Trials & Observations
Cameron S. Bader,Anna Pavlova,Robert Lowsky,Lori S. Muffly,Parveen Shiraz,Sally Arai,Laura J. Johnston,Andrew R. Rezvani,Wen-Kai Weng,David B. Miklos,Matthew J. Frank,John S. Tamaresis,Vaibhav Agrawal,Sushma Bharadwaj,Surbhi Sidana,Judith A. Shizuru,Nathaniel B. Fernhoff,Amy Putnam,Scott Killian,Bryan J. Xie,Robert S. Negrin,Everett H. Meyer
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
Clinical Trials & Observations
Birte Wistinghausen,Keri Toner,Donald A. Barkauskas,Lauren P Jerkins,Hannah Kinoshita,Pamela Chansky,Gloria Pezzella,Lauren Saguilig,Robert J. Hayashi,Harshal Abhyankar,Brooks Scull,Vivekanudeep Karri,Jay Tanna,Patrick Hanley,Michelle L. Hermiston,Carl E. Allen,Catherine M. Bollard
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study
Clinical Trials & Observations
Amir Enshaei,Melvin Joy,Ellie Butler,Amy A. Kirkwood,Monica Messina,Chiara Pavoni,Mireia Morgades,Christine J. Harrison,Robin Foà,Josep-Maria Ribera,Sabina Chiaretti,Renato Bassan,Adele K. Fielding,Anthony V. Moorman
Pediatric transplant–associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy
Clinical Trials & Observations
Michelle L. Schoettler,Leslie Lehmann,Pei-Chi Kao,Nan Chen,Sonata Jodele,Satheesh Chonat,Kirsten M. Williams,Wendy B. London,Christine Duncan,Christopher Dandoy
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis
Clinical Trials & Observations
Matthias H. Busch,Renée Ysermans,Joop P. Aendekerk,Sjoerd A. M. E. G. Timmermans,Judith Potjewijd,Jan G. M. C. Damoiseaux,Henri M. H. Spronk,Hugo ten Cate,Chris P. Reutelingsperger,Magdolna Nagy,Pieter van Paassen
HEALTH SERVICES AND OUTCOMES
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS
A. Vera de Jonge,Carolien Duetz,Wassilis S. C. Bruins,Charlotte L. B. M. Korst,Rosa Rentenaar,Meliha Cosovic,Merve Eken,Inoka Twickler,Marcel Nijland,Marjolein W. M. van der Poel,Koen de Heer,Clara P. W. Klerk,Leonie Strobbe,Margriet Oosterveld,Rinske Boersma,Harry R. Koene,Margaretha G. M. Roemer,Erik van Werkhoven,Martine E. D. Chamuleau,Tuna Mutis
LYMPHOID NEOPLASIA
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma
Ruth Flümann,Julia Hansen,Jörn Meinel,Pauline Pfeiffer,Hannah Goldfarb Wittkopf,Anna Lütz,Jessica Wirtz,Michael Möllmann,Tanja Zhou,Areya Tabatabai,Tim Lohmann,Maximilian Jauch,Filippo Beleggia,Benedikt Pelzer,Fabian Ullrich,Svenja Höfmann,Aastha Arora,Thorsten Persigehl,Reinhard Büttner,Bastian von Tresckow,Sebastian Klein,Ron D. Jachimowicz,Hans Christian Reinhardt,Gero Knittel
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
Clinical Trials & Observations
Ann Tivey,Rohan Shotton,Toby A. Eyre,David Lewis,Louise Stanton,Rebecca Allchin,Harriet Walter,Fiona Miall,Rui Zhao,Anna Santarsieri,Rory McCulloch,Mark Bishton,Amy Beech,Victoria Willimott,Nicole Fowler,Claudia Bedford,Jack Goddard,Sam Protheroe,Angharad Everden,David Tucker,Josh Wright,Vasavi Dukka,Miriam Reeve,Shankara Paneesha,Mahesh Prahladan,Andrew Hodson,Iman Qureshi,Manasvi Koppana,Mary Owen,Kushani Ediriwickrema,Helen Marr,Jamie Wilson,Jonathan Lambert,David Wrench,Claire Burney,Chloe Knott,Georgina Talbot,Adam Gibb,Angela Lord,Barry Jackson,Simon Stern,Taylor Sutton,Amy Webb,Marketa Wilson,Nicky Thomas,Jane Norman,Elizabeth Davies,Lisa Lowry,Jamie Maddox,Neil Phillips,Nicola Crosbie,Marcin Flont,Emma Nga,Andres Virchis,Raisa Guerrero Camacho,Wunna Swe,Arvind Pillai,Clare Rees,James Bailey,Steve Jones,Susan Smith,Faye Sharpley,Catherine Hildyard,Sajir Mohamedbhai,Toby Nicholson,Simon Moule,Anshuman Chaturvedi,Kim Linton
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy
Jessica F. Burlile,Kelsey M. Frechette,William G. Breen,Steven R. Hwang,Alexandra S. Higgins,Adrienne N. Nedved,William S. Harmsen,Sydney D. Pulsipher,Thomas E. Witzig,Ivana N. Micallef,Bradford S. Hoppe,Thomas M. Habermann,Gita Thanarajasingam,Patrick B. Johnston,David J. Inwards,N. Nora Bennani,Jennifer L. Peterson,Bradley J. Stish,William G. Rule,Stephen M. Ansell,Scott C. Lester
RNA-seq–based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia
Hirohito Kubota,Hiroo Ueno,Keiji Tasaka,Tomoya Isobe,Satoshi Saida,Itaru Kato,Katsutsugu Umeda,Mitsuteru Hiwatari,Daiichiro Hasegawa,Toshihiko Imamura,Nobuyuki Kakiuchi,Yasuhito Nannya,Seishi Ogawa,Hidefumi Hiramatsu,Junko Takita
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion
Caterina Tretti Parenzan,Anna Dal Molin,Giorgia Longo,Enrico Gaffo,Alessia Buratin,Alice Cani,Elena Boldrin,Valentina Serafin,Paola Guglielmelli,Alessandro M. Vannucchi,Giovanni Cazzaniga,Andrea Biondi,Franco Locatelli,Lueder H. Meyer,Barbara Buldini,Geertruij te Kronnie,Silvia Bresolin,Stefania Bortoluzzi
MYELOID NEOPLASIA
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
Onyee Chan,Najla Al Ali,Hammad Tashkandi,Austin Ellis,Somedeb Ball,Justin Grenet,Caroline Hana,Yehuda Deutsch,Ling Zhang,Mohammad Hussaini,Jinming Song,Seongseok Yun,Chetasi Talati,Andrew Kuykendall,Eric Padron,Alison Walker,Gail Roboz,Pinkal Desai,David Sallman,Kendra Sweet,Rami Komrokji,Jeffrey Lancet
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells
Shivam Rai,Yang Zhang,Elodie Grockowiak,Quentin Kimmerlin,Nils Hansen,Cedric B. Stoll,Marc Usart,Damien Luque Paz,Hui Hao-Shen,Yexuan Zhu,Julien Roux,Michael S. Bader,Stefan Dirnhofer,Christopher J. Farady,Timm Schroeder,Simón Méndez-Ferrer,Radek C. Skoda
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN
Marta B. Davidson,James A. Kennedy,Jose-Mario Capo-Chichi,Yuliang Shi,Wei Xu,Verna Cheung,Andrea Arruda,Aniket Bankar,Guillaume Richard-Carpentier,Steven Chan,Dawn Maze,Mark D. Minden,Aaron D. Schimmer,Andre C. Schuh,Hassan Sibai,Karen Yee,Anne Tierens,Auro Viswabandya,Vikas Gupta
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis
Takashi Toya,Kota Mizuno,Masatoshi Sakurai,Jun Kato,Takehiko Mori,Noriko Doki,Shinichi Masuda,Nobuyuki Aotsuka,Shokichi Tsukamoto,Emiko Sakaida,Yuki Nakajima,Shin Fujisawa,Shinichiro Machida,Yasuyuki Aoyama,Hiroki Yokoyama,Katsuhiro Shono,Yoshihiro Hatta,Kensuke Usuki,Keisuke Kataoka,Yoshinobu Kanda
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation
Curtis Marcoux,Rima M. Saliba,Whitney Wallis,Sajad Khazal,Dristhi Ragoonanan,Gabriela Rondon,Priti Tewari,Uday Popat,Betul Oran,Amanda Olson,Qaiser Bashir,Muzaffar Qazilbash,Amin Alousi,Chitra Hosing,Yago Nieto,Gheath Alatrash,David Marin,Katayoun Rezvani,Issa Khouri,Samer Srour,Richard Champlin,Elizabeth Shpall,Partow Kebriaei
VASCULAR BIOLOGY
Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages
Florent Lebrun,Damien Levard,Eloïse Lemarchand,Mervé Yetim,Jonathane Furon,Fanny Potzeha,Pauline Marie,Flavie Lesept,Manuel Blanc,Benoit Haelewyn,Marina Rubio,Annelise Letourneur,Nicolas Violle,Cyrille Orset,Denis Vivien
RESEARCH LETTERS
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
B. Bishal Paudel,Su-Fern Tan,Todd E. Fox,Johnson Ung,Upendarrao Golla,Jeremy J. P. Shaw,Wendy Dunton,Irene Lee,Wisam A. Fares,Satyam Patel,Arati Sharma,Aaron D. Viny,Brian M. Barth,Martin S. Tallman,Myles Cabot,Francine E. Garrett-Bakelman,Ross L. Levine,Mark Kester,David J. Feith,David Claxton,Kevin A. Janes,Thomas P. Loughran, Jr.
ERRATUM
-
Cover Image
Cover Image
Proximity ligation assays (PLAs) were deployed to detect the colocalization of the toll-like receptor adaptor protein myeloid differentiation primary response 88 (MYD88) and Bruton’s tyrosine kinase. The PLAs were performed on formalin-fixed paraffin-embedded tissue sections derived from murine lymphomas isolated from Cd19Cre/wt;Myd88c.-p.L252P/wt; Rosa26LSL.BCL2.IRES.GFP/wt;Prdm1fl/fl;Cd79bc.-p.Y195H/wt mice that were treated with ibrutinib (30 mg/kg orally daily for 3 days) prior to lymphoma isolation. PLA foci are visualized in yellow, and the B-cell–specific antigen B220 (violet) was used to determine cell numbers. See the article by Flümann et al.
Advertisement
Advertisement
Add-on erythropoietin in autoimmune hemolytic anemia
Clinical Trials & Observations